CB Insights
Technology Market Intelligence
Technology Market Intelligence
AbbVie (NYSE: ABBV) consists of scientists, researchers, communicators, manufacturing specialists and regulatory professionals who seek to come up with new approaches to addressing today's health issues-from life-threatening illness to chronic condit...Show all
Company (Alive / Active)
Phone: 800-255-5162
One North Waukegan Road
North Chicago, 60064
Illinois, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| AbbVie | $0M | Dec 30, 2020 |
| Sumitovant | $0M | Dec 30, 2020 |
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Company | Status | Description | Investors |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Anti-4-1bb antibodies and their uses | May 26, 2017 | Dec 29, 2020 | Patent |
| High purity oritavancin and method of producing same | Jun 11, 2019 | Dec 15, 2020 | Patent |
| Modulators of the integrated stress pathway | May 05, 2017 | Dec 15, 2020 | Patent |
| Automatic injection device | May 25, 2018 | Dec 08, 2020 | Patent |
| Protein tyrosine phosphatase inhibitors and methods of use thereof | Jun 04, 2020 | Dec 01, 2020 | Patent |
